In addition to disrupting inflammation, recent studies demonstrated that SIRT1 inhibits NF-κB to suppress various metabolic diseases, including glucose homeostasis and cardiovascular disease [35, 37]. The gene discussed is SIRT1; the disease is metabolic disease.